Impact of high-protein enteral nutrition on muscle preservation in mechanically ventilated patients with severe pneumonia: a randomized controlled trial.
Diaphragmatic thickness
Enteral nutrition
Muscle wasting
Quadriceps muscle layer thickness
Severe pneumonia
Journal
Journal of health, population, and nutrition
ISSN: 2072-1315
Titre abrégé: J Health Popul Nutr
Pays: Bangladesh
ID NLM: 100959228
Informations de publication
Date de publication:
28 Sep 2024
28 Sep 2024
Historique:
received:
21
06
2024
accepted:
26
08
2024
medline:
29
9
2024
pubmed:
29
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
This study aimed to assess the effects of enteral nutrition with different protein concentrations on muscle mass in severe pneumonia patients, providing insights for enteral nutrition practice in intensive care units (ICUs). A total of 120 severe pneumonia patients admitted to Dazhou Central Hospital's ICU between June 1, 2022, and February 1, 2023, meeting inclusion criteria, were randomly assigned to either a high-protein group (n = 60, 1.8 g/kg/d) or a standard-protein group (n = 60, 1.2 g/kg/d). Changes in relevant indicators were monitored on days 1, 5, and 10 of ICU admission, including quadriceps and diaphragm thickness, nutritional status (prealbumin and albumin), and adverse events such as diarrhea and constipation. Autoregressive of order 1 model (AR(1)) analysis revealed a decrease in both quadriceps and diaphragm thickness over time in both groups. A significant group × time interaction was observed in quadriceps thickness. By day 10, compared to baseline, quadriceps thickness decreased in the high-protein (-0.315 cm [95% CI, -0.340 to -0.289]) and standard-protein (-0.429 cm [95% CI, -0.455 to -0.404]) groups. The high-protein group exhibited a lower quadriceps atrophy rate (13.97 ± 2.43%) compared to the standard-protein group (18.96 ± 2.61%), showing a significant difference (P < 0.001). No significant differences were found in diaphragmatic thickness between groups and over time. By day 10, both groups exhibited decreased diaphragmatic muscle thickness compared to baseline. The high-protein group (33.76 ± 5.09%) had a slightly lower phrenic atrophy rate compared to the standard-protein group (33.41 ± 4.53%). Both groups experienced enteral nutritional intolerance manifested as diarrhea, constipation, and other adverse events. High-protein enteral nutrition significantly improved quadriceps thickness and demonstrated good safety in severe pneumonia patients, suggesting its suitability for widespread clinical application.
Sections du résumé
BACKGROUND
BACKGROUND
This study aimed to assess the effects of enteral nutrition with different protein concentrations on muscle mass in severe pneumonia patients, providing insights for enteral nutrition practice in intensive care units (ICUs).
METHODS
METHODS
A total of 120 severe pneumonia patients admitted to Dazhou Central Hospital's ICU between June 1, 2022, and February 1, 2023, meeting inclusion criteria, were randomly assigned to either a high-protein group (n = 60, 1.8 g/kg/d) or a standard-protein group (n = 60, 1.2 g/kg/d). Changes in relevant indicators were monitored on days 1, 5, and 10 of ICU admission, including quadriceps and diaphragm thickness, nutritional status (prealbumin and albumin), and adverse events such as diarrhea and constipation.
RESULTS
RESULTS
Autoregressive of order 1 model (AR(1)) analysis revealed a decrease in both quadriceps and diaphragm thickness over time in both groups. A significant group × time interaction was observed in quadriceps thickness. By day 10, compared to baseline, quadriceps thickness decreased in the high-protein (-0.315 cm [95% CI, -0.340 to -0.289]) and standard-protein (-0.429 cm [95% CI, -0.455 to -0.404]) groups. The high-protein group exhibited a lower quadriceps atrophy rate (13.97 ± 2.43%) compared to the standard-protein group (18.96 ± 2.61%), showing a significant difference (P < 0.001). No significant differences were found in diaphragmatic thickness between groups and over time. By day 10, both groups exhibited decreased diaphragmatic muscle thickness compared to baseline. The high-protein group (33.76 ± 5.09%) had a slightly lower phrenic atrophy rate compared to the standard-protein group (33.41 ± 4.53%). Both groups experienced enteral nutritional intolerance manifested as diarrhea, constipation, and other adverse events.
CONCLUSION
CONCLUSIONS
High-protein enteral nutrition significantly improved quadriceps thickness and demonstrated good safety in severe pneumonia patients, suggesting its suitability for widespread clinical application.
Identifiants
pubmed: 39342405
doi: 10.1186/s41043-024-00633-0
pii: 10.1186/s41043-024-00633-0
doi:
Substances chimiques
Dietary Proteins
0
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
152Informations de copyright
© 2024. The Author(s).
Références
Niederman MS, Torres A. Severe community-acquired pneumonia. Eur Respir Rev. 2022;31(166):220123.
doi: 10.1183/16000617.0123-2022
pubmed: 36517046
pmcid: 9879347
Martin-Loeches I, Torres A. New guidelines for severe community-acquired pneumonia. Curr Opin Pulm Med. 2021;27(3):210–5.
doi: 10.1097/MCP.0000000000000760
pubmed: 33405483
Wandrag L, Brett SJ, Frost GS, Bountziouka V, Hickson M. Exploration of muscle loss and metabolic state during prolonged critical illness: implications for intervention. PLoS ONE. 2019;14(11):e0224565.
doi: 10.1371/journal.pone.0224565
pubmed: 31725748
pmcid: 6855435
van Gassel R, Baggerman MR, van de Poll M. Metabolic aspects of muscle wasting during critical illness. Curr Opin Clin Nutr Metab Care. 2020;23(2):96–101.
doi: 10.1097/MCO.0000000000000628
pubmed: 31904602
pmcid: 7015189
Lee ZY, Ong SP, Ng CC, et al. Association between ultrasound quadriceps muscle status with premorbid functional status and 60-day mortality in mechanically ventilated critically ill patient: a single-center prospective observational study. Clin Nutr. 2021;40(3):1338–47.
doi: 10.1016/j.clnu.2020.08.022
pubmed: 32919818
Brook MS, Wilkinson DJ, Atherton PJ. An update on nutrient modulation in the management of disease-induced muscle wasting: evidence from human studies. Curr Opin Clin Nutr Metab Care. 2020;23(3):174–80.
doi: 10.1097/MCO.0000000000000652
pubmed: 32175954
Allingstrup MJ, Esmailzadeh N, Wilkens Knudsen A, et al. Provision of protein and energy in relation to measured requirements in intensive care patients. Clin Nutr. 2012;31(4):462–8.
doi: 10.1016/j.clnu.2011.12.006
pubmed: 22209678
Nicolo M, Heyland DK, Chittams J, Sammarco T, Compher C. Clinical outcomes related to protein delivery in a critically Ill Population: a multicenter, multinational Observation Study. JPEN J Parenter Enter Nutr. 2016;40(1):45–51.
doi: 10.1177/0148607115583675
Ferrie S, Allman-Farinelli M, Daley M, Smith K. Protein requirements in the critically ill: a Randomized Controlled Trial using Parenteral Nutrition. JPEN J Parenter Enter Nutr. 2016;40(6):795–805.
doi: 10.1177/0148607115618449
Fetterplace K, Deane AM, Tierney A, et al. Targeted full energy and protein delivery in critically ill patients: a pilot randomized controlled trial (FEED trial). JPEN J Parenter Enter Nutr. 2018;42(8):1252–62.
doi: 10.1002/jpen.1166
van Zanten A, Petit L, De Waele J, et al. Very high intact-protein formula successfully provides protein intake according to nutritional recommendations in overweight critically ill patients: a double-blind randomized trial. Crit Care. 2018;22(1):156.
doi: 10.1186/s13054-018-2070-5
pubmed: 29895309
pmcid: 5998555
Yeh DD, Ortiz LA, Lee JM, et al. PEP uP (enhanced protein-energy provision via the Enteral Route Feeding Protocol) in Surgical Patients-A Multicenter Pilot Randomized Controlled Trial. JPEN J Parenter Enter Nutr. 2020;44(2):197–204.
doi: 10.1002/jpen.1521
Landi F, Camprubi-Robles M, Bear DE, et al. Muscle loss: the new malnutrition challenge in clinical practice. Clin Nutr. 2019;38(5):2113–20.
doi: 10.1016/j.clnu.2018.11.021
pubmed: 30553578
Kortebein P, Ferrando A, Lombeida J, Wolfe R, Evans WJ. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA. 2007;297(16):1772–4.
doi: 10.1001/jama.297.16.1772-b
pubmed: 17456818
Paris M, Mourtzakis M. Assessment of skeletal muscle mass in critically ill patients: considerations for the utility of computed tomography imaging and ultrasonography. Curr Opin Clin Nutr Metab Care. 2016;19(2):125–30.
doi: 10.1097/MCO.0000000000000259
pubmed: 26808266
Nakamura K, Nakano H, Naraba H, Mochizuki M, Takahashi Y, Sonoo T, Hashimoto H, Morimura N. High protein versus medium protein delivery under equal total energy delivery in critical care: a randomized controlled trial. Clin Nutr. 2021;40(3):796–803. https://doi.org/10.1016/j.clnu.2020.07.036 .
doi: 10.1016/j.clnu.2020.07.036
pubmed: 32800385
Coffman CJ, Edelman D, Woolson RF. To condition or not condition? Analysing ‘change’ in longitudinal randomised controlled trials. BMJ Open. 2016;6(12):e013096.
doi: 10.1136/bmjopen-2016-013096
pubmed: 28039292
pmcid: 5223669
Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, Heyland DK. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med. 2009;35(10):1728–37. https://doi.org/10.1007/s00134-009-1567-4 .
doi: 10.1007/s00134-009-1567-4
pubmed: 19572118
Mitchell A, Clemente R, Downer C, Greer F, Allan K, Collinson A, Taylor S. Protein provision in critically ill adults requiring Enteral Nutrition: are guidelines being Met. Nutr Clin Practice: Official Publication Am Soc Parenter Enter Nutr. 2019;34(1):123–30. https://doi.org/10.1002/ncp.10209 .
doi: 10.1002/ncp.10209
Weijs P, Mogensen KM, Rawn JD, Christopher KB. Protein intake, Nutritional Status and outcomes in ICU survivors: a single Center Cohort Study. J Clin Med. 2019;8(1):43. https://doi.org/10.3390/jcm8010043 .
doi: 10.3390/jcm8010043
pubmed: 30621154
pmcid: 6352154
Dresen E, Weißbrich C, Fimmers R, Putensen C, Stehle P. Medical high-protein nutrition therapy and loss of muscle mass in adult ICU patients: a randomized controlled trial. Clin Nutr. 2021;40:1562–70.
doi: 10.1016/j.clnu.2021.02.021
pubmed: 33743292
Schepens T, Verbrugghe W, Dams K, Corthouts B, Parizel PM, Jorens PG. The course of diaphragm atrophy in ventilated patients assessed with ultrasound: a longitudinal cohort study. Crit Care. 2015;19:422.
doi: 10.1186/s13054-015-1141-0
pubmed: 26639081
pmcid: 4671211
Grassi A, Ferlicca D, Lupieri E, Calcinati S, Francesconi S, Sala V, et al. Assisted mechanical ventilation promotes recovery of diaphragmatic thickness in critically ill patients: a prospective observational study. Crit Care. 2020;24:85.
doi: 10.1186/s13054-020-2761-6
pubmed: 32164784
pmcid: 7068963
Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Mol Aspects Med. 2012;33(3):209–90. https://doi.org/10.1016/j.mam.2011.12.002 .
doi: 10.1016/j.mam.2011.12.002
pubmed: 22230555
Chapple LS, Summers MJ, Bellomo R, Chapman MJ, Davies AR, Ferrie S, Finnis ME, Hurford S, Lange K, Little L, O’Connor SN, Peake SL, Ridley EJ, Young PJ, Williams PJ, Deane AM. Use of a high-protein Enteral Nutrition Formula to increase protein delivery to critically ill patients: a Randomized, Blinded, Parallel-Group, feasibility trial. JPEN J Parenter Enteral Nutr. 2021;45(4):699–709. https://doi.org/10.1002/jpen.2059 .
doi: 10.1002/jpen.2059
pubmed: 33296079
Rugeles SJ, Rueda JD, Díaz CE, Rosselli D. Hyperproteic hypocaloric enteral nutrition in the critically ill patient: a randomized controlled clinical trial. Indian J Crit care Medicine: peer-reviewed Official Publication Indian Soc Crit Care Med. 2013;17(6):343–9. https://doi.org/10.4103/0972-5229.123438 .
doi: 10.4103/0972-5229.123438